Screener / SEC EDGAR /CIK 0001515673 /10-K filed Feb 18, 2026, compared with Feb 19, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Pharmaceuticals

Ultragenyx Pharmaceutical Inc. RARE

Compare with peers Embed
Who owns RARE

Institutional owners are on their way

13F data can be up to 45 days old

We read every 13F filing after each quarter ends. The owners of RARE show here after the next update.

Institutional ownership

Institutional owners

13F data sets, SEC

Institutional owners are on their wayWe read every 13F filing after each quarter ends. The owners of RARE show here after the next update.

Funds that hold RARE

Mutual funds and ETFs, each from its own latest portfolio report. Funds report on their own quarter ends.

Form N-PORT, SEC

Fund holdings are on their wayWe read the funds' N-PORT reports after each quarter. The funds that hold RARE show here after the next update.

Superinvestors holding RARE

The investors followed on Tickdelta, from their latest 13F.

All investors

None of the followed investors held RARE in their latest 13F.

13D filings: owners who may push for change

Owners of more than 5%

Schedule 13D, last year

No Schedule 13D about RARE in the last year.

Sources

SEC's Form 13F data sets, each quarter; Form N-PORT data sets for the funds; Schedule 13D filings.

Also

Investors: the portfolios of the superinvestors followed here. Insider trades: what the company's own people bought and sold.

Work with it

Excel workbook · CSV

Next:Cash & buybacks
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.